Study Overview/Requirements

The following is a breakdown of the overview and requirements for upcoming studies. If you find patients that meet these criteria, please contact Redpoint Research. As with many studies enrollment space is limited. Please contact us for information regarding new studies that are not yet listed on our website.

Hypertension:

High Blood Pressure enrollment is closed.

Check back soon for new hypertension studies.

 

Coordinator: Susy Pratt

Diabetes Studies:

Diabetes Type II

What Kind of Insulin?

Announcing the OPTiiON Study, a clinical trial of an investigational inhaled insulin.

Why an investigational inhaled insulin?

The body's initial response to rising blood sugar after a meal is a rapid release of insulin from the pancreas. In those of us with diabetes, this rapid release of insulin is limited or lost. In people with type 1 diabetes, the pancreas no longer makes insulin at all. People with type 2 diabetes are able to make insulin, but their bodies don't respond well to it.

In the OPTiiON study, doctors are testing an investigational rapid-onset insulin powder that is inhaled through a pocket-sized device.

For further information about diabetes, visit the American Diabetes Association's web site www.diabetes.org.

How can I participate in this study?

You may be eligible to participate if you:

• are 18 to 80 years old
• were diagnosed more than 6 months ago with type 2 diabetes
• are in good general health otherwise
• do not smoke and have not smoked within the past 6 months
• have no history of asthma or chronic obstructive pulmonary disease
• take metformin (example: Glucophage®) plus one other oral anti-diabetic drug
• are not currently taking insulin

Note: a review of your previous medical records may be necessary to confirm your eligibility. You may be asked to sign a release form to permit this review.

If you are eligible to participate, you will receive diabetic counseling, and you may receive for up to 6 months:

• Investigational inhaled insulin
• Compensation for your time and travel

You're too busy to let diabetes run your life.

Call today to learn more about the OPTiiON study

602-395-1200

Herbert Goodman M.D.

Redpoint Research

11045 N. 19th Ave., Ste 2

Phoenix, AZ 85029

 

Coordinator: Susy Pratt

 

Diabetes Type I and II

VOLUMEStudy

Do you have Diabetes?

Learn more about the

VOLUME Study

What is the VOLUME Study?

Most patients with type 1 or type 2 diabetes take medication in the form of either a pill or injection. Some patients may take both.

EXUBERA®, an approved inhaled insulin, provides an alternative to insulin injection in the form of a medicine that is inhaled through the mouth to control blood sugar. Both short-acting insulin injections and inhaled insulin (EXUBERA®) provide the same blood lowering effect to treat diabetes.

If you are living with diabetes and interested in participating in a clinical study, you may qualify to take part in the VOLUME Study. The VOLUME Study is a 5-year research study to compare two diabetes treatment regimens. This study is sponsored by a major pharmaceutical company.

The VOLUME Study is now being conducted by doctors in your area. Your doctor can evaluate whether you may qualify to participate in this clinical study. To qualify, you must be 18 years of age or older and have diabetes.

Why should I participate?

By taking part in the VOLUME Study, you may help researchers understand more about the safety of EXUBERA® and other diabetes medicines. If you qualify, you may receive up to 5 years of study-related care at no cost to you.

What will be my responsibility?

Those who qualify will be enrolled in the study and will be required to:

• Sign an Informed Consent
• Follow the treatment plan explained to you by your doctor.
• Attend all scheduled appointments with your study doctor for the next 5 years.

If you are enrolled and decide you no longer want to participate in this voluntary study, you may end your participation at any time.

What is informed consent?

Before enrolling in a clinical research study, patients are required to sign a form indicating that they understand the research study and agree to participate. This form will explain the treatment you will receive, the kind of problems that might occur, the required study appointment schedule, and that there are other treatment options for your condition.

Giving consent entitles you to all legal rights as a research patient, including the right to leave the study at any time.

How do I qualify?

To enter this study, talk to your doctor about being considered for participation. Your doctor will determine if you qualify and then guide you through the study process.

Privacy

Study doctors and their staff will respect the privacy of all patients who take part in the VOLUME Study. Details about your diabetes will be kept confidential. Your study visits will be held in medical offices under the supervision of a study doctor and will be conducted in accordance with all legal and regulatory requirements.

Please talk to your doctor about taking part in the VOLUME Study.

Your doctor may have mentioned the VOLUME Stud to you - a research study comparing EXUBERA® (insulin human [rDNA origin])Inhalation Power with standard diabetes care for the control of diabetes mellitus.

 

Coordinator: Susy Pratt

GastroIntestinal:

Opioid Induced Constipation

 

Study is closed

 

Coordinator: Susy Pratt

 

Irritable Bowel Syndrome

DO YOU HAVE IBS?

Do you have chronic abdominal pain or discomfort that is accompanied by a change in your normal number of bowel movements and/or a change in the form (appearance) of you stool? If so, you might have a medical condition known as Irritable Bowel Syndrome or IBS.

We are looking for men and women with IBS to participate in a clinical research study of an investigational medication for the treatment of the abdominal pain or discomfort associated with IBS.

You may qualify for the study if you meet the following criteria:

• Between the ages of 18 and 79 years;
• Diagnosed or have been diagnosed with IBS as a result of having at least 6 months, not necessarily consecutive, in the preceding 12 months of recurrent symptoms of abdominal discomfort or pain that is:
  • Relieved with defecation,
  • Associated with a change in your typical number of bowel movements when the abdominal pain or discomfort begins, and/or
  • Associated with a change in form (appearance) of stool when the abdominal pain or discomfort begins,
• Experiencing at least moderate abdominal pain or discomfort, and
• Have undergone a flexible sigmoidoscopy or colonoscopy with normal results in the past 3 years, or are willing to undergo these procedures.

All participants in this study will receive study medication, office visits, and study-related medical procedures at no cost.

If you are interested in receiving more information, or to see if you qualify, please contact Teresa Laborin at (602)395-1200.

 

Coordinator: Juan Castro

 

Pain:

 

Chronic Pain

Clinical Research Study for Chronic Pain Patients

Now Enrolling!

To qualify, you must be:

• 40 years or older
• Suffering from chronic pain: lower back pain, osteoarthritis, rheumatoid arthritis, or other joint-related pain
• Interested in participating in a clinical study that closely monitors your health

Study participation includes, at no cost to you:

• Study visits with experienced medical professionals
• Study drug for up to 7 months
• Study procedures and evaluations

Compensation for time and travel will be provided

 

 

Coordinator: Susy Pratt

 

Misc:

New Studies

 

Several new studies have not been yet listed. Please call us or e-mail us to get information.

Coordinator: Susy Pratt